A landmark 2025 meta-analysis published in the Journal of the American College of Cardiology pooled 21 randomized controlled trials covering 99,599 patients and found high-certainty evidence that GLP-1 receptor agonists produced: 12% reduction in all-cause death (IRR 0.88
The new WeightWatchers GLP-1 Program is available to members in the U.S., U.K
Dry your hands thoroughly with a clean towel
If you have type 2 diabetes, Ozempic might give you the dual benefit of better blood sugar control and weight loss
Thalidomide was administered more out of despair than of conviction, and the results were surprisingly favourable. Dr
By combining medication, medical oversight, nutrition, coaching, and community into one experience, the brand has created something that feels far more supportive than a typical prescription-only approach